Shanthi Rexaline

Shanthi is a contributor to and works as a Staff Writer with Benzinga. Equipped with a Bachelor’s degree in Agriculture and an MBA with specialization in finance and marketing, she has about two decades of experience in financial reporting and analysis, and specializes in the biopharma and EV sectors.

Recent Articles

Nio Stock Flashes a Buy Signal as Fundamentals Look Set to Inflect Higher

Nio could be in for a strong rebound, when cautious investors take cognizance of the fundamental prospects amid the anticipated improvement in economic and geopolitical situation.

6 Biotech Stocks to Buy Now Ahead of These June Catalysts

Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way.

3 Biotech Stocks to Buy Before They Boom

It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations.

7 Electric Vehicle Stocks That Wall Street Analysts Love

The worst may be behind for electric vehicle stocks as manufacturers emerge out of the crises induced by geopolitical tensions .

5 Oversold Cybersecurity Stocks to Buy Now

Cybersecurity stocks are poised to outperform the broader tech sector and the oversold nature of some of these give an added reason to buy them.